DBT
GHDX

Dubuque Bank & Trust’s Genomic Health, Inc. GHDX Stock Holding History

Dubuque Bank & Trust’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-254
Closed -$18K – 682
2019
Q1 		$18K Hold
254
– – ﹤0.01% 400
2018
Q4 		$16K Hold
254
– – ﹤0.01% 386
2018
Q3 		$18K Hold
254
– – ﹤0.01% 374
2018
Q2 		$13K Sell
254
-73
-22% -$2.9K ﹤0.01% 440
2018
Q1 		$10K Sell
327
-4,742
-94% -$157K ﹤0.01% 502
2017
Q4 		$173K Sell
5,069
-72
-1% -$2.3K 0.03% 237
2017
Q3 		$165K Buy
5,141
+244
+5% +$7.7K 0.03% 238
2017
Q2 		$159K Buy
4,897
+379
+8% +$12K 0.03% 223
2017
Q1 		$142K Buy
+4,518
New +$134K 0.03% 232

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dubuque Bank & Trust's GHDX Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 254 shares — an estimated $18K sold.

Dubuque Bank & Trust first reported a position in GHDX in Q1 2017 and held it in 9 quarters. The position peaked at $173K in Q4 2017. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 254 Genomic Health, Inc. shares in Q2 2019, an estimated $18K.
  • Dubuque Bank & Trust first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 9 quarters.
  • Dubuque Bank & Trust's Genomic Health, Inc. position peaked at $173K in Q4 2017.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.